Alternatives to Imagene

AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.

AI-powered spatial biology platform for precision medicine and drug development.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Harnessing genetic data for digital insights in rare and germline disorders.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Developing novel diagnostics to predict patient response to immunotherapy.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Leveraging the adaptive immune system to diagnose and treat disease.

A medical platform connecting patients and physicians with genetic expertise.

Developing AI-driven technology for mental health treatments, focusing on PTSD.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Sensifai desarrolla reconocimiento potenciado por IA, soluciones DeFi seguras y plataformas Web3 innovadoras.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

AI-powered platform for personalized cell therapy development and manufacturing.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

AI-powered breast cancer detection and risk assessment solutions.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

Develops a computational model of the human body for drug discovery and development.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

AI-powered platform for antibody discovery and development to create new medicines.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Personalized nutrition and metabolic health platform using gut microbiome and AI.